TherapeuticsMD (TXMD) Proxy Filing summary

Voting matters and shareholder proposals

• Election of four directors to serve until the next annual meeting or until successors are elected and qualified.

• Advisory vote to approve executive compensation for the fiscal year ended December 31, 2023.

• Ratification of Berkowitz Pollack Brant Advisors + CPAs, LLP as independent auditor for the fiscal year ending December 31, 2024.

• Other business may be transacted as may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends a vote in favor of all proposals presented at the annual meeting.

• Director nominees include Tommy G. Thompson, Cooper C. Collins, Gail K. Naughton, Ph.D., and Justin Roberts.

Executive compensation and say-on-pay

• Advisory vote scheduled to approve compensation of named executive officers for the prior fiscal year.